French generic medicine manufacturer, Biogaran has announced the acquisition of Nigeria’s Swiss Pharmaceutical company (Swipha) under a deal that would see the new owners intensifying local production of drugs in the country.
Femi Adekoya
The News You Need, Delivered To You.
Subscribe to the Guardian today and never miss the stories that shape your Business